Joseph E. Payne - 25 May 2021 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Director
Signature
/s/ David Baker, attorney-in-fact
Issuer symbol
GRI
Transactions as of
25 May 2021
Net transactions value
+$71,795
Form type
4
Filing time
27 May 2021, 20:37:49 UTC
Previous filing
18 May 2021
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRI Common Stock Purchase $41,195 +10,700 $3.85 10,700 25 May 2021 Direct
transaction GRI Common Stock Purchase $30,600 +6,800 +64% $4.50 17,500 26 May 2021 Direct
holding GRI Common Stock 843,750 25 May 2021 By Arcturus Therapeutics, Inc. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.